
New York’s Medicaid program says Orkambi, a new drug to treat cystic fibrosis, is not worth the price. The case is being closely watched around the country. KATIE THOMAS https://ift.tt/2toIJWM https://ift.tt/2lyjehA The New York Times Health Drugs (Pharmaceuticals), Health Insurance and Managed Care June 24, 2018 at 12:00AM
Comments
Post a Comment